Tue, May 18, 2021
Mon, May 17, 2021
Fri, May 14, 2021
Thu, May 13, 2021
Wed, May 12, 2021
Tue, May 11, 2021
Mon, May 10, 2021
Fri, May 7, 2021

David Lebowitz Maintained (SNDX) at Hold with Decreased Target to $20 on, May 12th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-20-on-may-12th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Lebowitz of Morgan Stanley, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Hold with Decreased Target from $25 to $20 on, May 12th, 2021.

David, nor any peers, have made any analyst calls on SNDX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Publication Contributing Sources